Malignant pleural effusions are common in patients with cancer. Most malignant pleural
effusions are secondary to metastases to the pleura, most often from lung or breast cancer …

Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. MPE is a
common symptom and accompanying manifestation of metastatic disease. It affects up to …

Purpose Most malignant effusion is secondary to metastases to the pleura or peritoneum
and portend poor oncological outcomes. Malignant effusion has different tumor …

Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a
common and effective treatment. There are no reliable data, however, regarding the optimal …

The use of biomarkers on pleural fluid (PF) specimens may assist the decision-making
process and enhance clinical diagnostic pathways. Three paradigmatic examples are heart …

Background Thoracentesis and thoracoscopy are used to diagnose malignant pleural
effusions (MPE). Data on how sensitivity varies with tumour type is limited. Methods …

Malignant pleural mesothelioma is an aggressive, incurable cancer that is usually caused by
asbestos exposure several decades before symptoms arise. Despite widespread prohibition …

The complex interactions among different immune cells have important functions in the
development of malignant pleural effusion (MPE). Here we perform single-cell RNA …

Simple Summary Mesothelioma is a cancer of the lining of the lungs caused by breathing in
asbestos fibres. Asbestos was widely used in industry in the last century in most developed …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …